RAPT Therapeutics, Inc.
CHEMOKINE RECEPTOR MODULATORS AND USES THEREOF
Last updated:
Abstract:
Disclosed herein, inter alia, are compounds and methods of use thereof for the modulation of CCR4 activity.
Status:
Application
Type:
Utility
Filling date:
28 Jan 2020
Issue date:
30 Jul 2020